HAE
HAEMONETICS CORP
Next earnings Aug 5, 2026 · consensus $1.10 EPS, $332M rev
Last earnings +3.2% on 2026-05-07
$77.62
▲ +6.52%$77.62▲ +9.20%
over 1Y
L $47.67EODHDH $87.16
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+6.5%
1W+4.7%
1M+16.1%
3M+39.8%
YTD-3.0%
1Y+9.2%
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 15 analysts
Buy
Quality medtech franchise hit an earnings air-pocket; levered balance sheet and 35x P/E argue for patience, not chase.
Sources: SEC EDGAR (CIK 0000313143, latest 10-K filed 2026-05-20) · EODHD · analysis by claude-code · as of 6/25/2026, 1:38:47 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.